rs182804464

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001848.3(COL6A1):​c.1814-6C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0123 in 1,613,892 control chromosomes in the GnomAD database, including 182 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0089 ( 14 hom., cov: 35)
Exomes 𝑓: 0.013 ( 168 hom. )

Consequence

COL6A1
NM_001848.3 splice_region, intron

Scores

2
Splicing: ADA: 0.03446
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.475
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 21-46000753-C-G is Benign according to our data. Variant chr21-46000753-C-G is described in ClinVar as [Benign]. Clinvar id is 93830.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46000753-C-G is described in Lovd as [Benign]. Variant chr21-46000753-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0089 (1356/152340) while in subpopulation NFE AF= 0.0137 (935/68022). AF 95% confidence interval is 0.013. There are 14 homozygotes in gnomad4. There are 664 alleles in male gnomad4 subpopulation. Median coverage is 35. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL6A1NM_001848.3 linkuse as main transcriptc.1814-6C>G splice_region_variant, intron_variant ENST00000361866.8 NP_001839.2 P12109A0A384P5H7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkuse as main transcriptc.1814-6C>G splice_region_variant, intron_variant 1 NM_001848.3 ENSP00000355180.3 P12109
COL6A1ENST00000466285.1 linkuse as main transcriptn.331-6C>G splice_region_variant, intron_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00893
AC:
1359
AN:
152222
Hom.:
14
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0187
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0138
Gnomad OTH
AF:
0.00861
GnomAD3 exomes
AF:
0.0101
AC:
2545
AN:
251424
Hom.:
30
AF XY:
0.0101
AC XY:
1373
AN XY:
135890
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.00211
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00274
Gnomad FIN exome
AF:
0.0194
Gnomad NFE exome
AF:
0.0161
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.0126
AC:
18448
AN:
1461552
Hom.:
168
Cov.:
35
AF XY:
0.0123
AC XY:
8963
AN XY:
727118
show subpopulations
Gnomad4 AFR exome
AF:
0.00206
Gnomad4 AMR exome
AF:
0.00206
Gnomad4 ASJ exome
AF:
0.00283
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00371
Gnomad4 FIN exome
AF:
0.0201
Gnomad4 NFE exome
AF:
0.0146
Gnomad4 OTH exome
AF:
0.00976
GnomAD4 genome
AF:
0.00890
AC:
1356
AN:
152340
Hom.:
14
Cov.:
35
AF XY:
0.00891
AC XY:
664
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.00255
Gnomad4 AMR
AF:
0.00333
Gnomad4 ASJ
AF:
0.00374
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.0187
Gnomad4 NFE
AF:
0.0137
Gnomad4 OTH
AF:
0.00852
Alfa
AF:
0.00517
Hom.:
2
Bravo
AF:
0.00756
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0109
EpiControl
AF:
0.0115

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxMar 04, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 24, 2012- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsOct 30, 2018- -
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
12
DANN
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.034
dbscSNV1_RF
Benign
0.15
SpliceAI score (max)
0.21
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.21
Position offset: -39
DS_AL_spliceai
0.20
Position offset: 6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs182804464; hg19: chr21-47420667; API